GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
This study has been completed.
Sponsor:
CoMentis
Information provided by:
CoMentis
ClinicalTrials.gov Identifier:
NCT00414622
First received: December 19, 2006
Last updated: April 18, 2007
Last verified: December 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2007 |
| Estimated Primary Completion Date: | No date given |